ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2016
Preparing for an Aging World: Engaging Biogerontologists, Geriatricians, and the Society.
Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Self-Care for the Prevention and Management of Cardiovascular Disease and Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association.Journal of the American Heart Association · 2017Guideline
- Strength gains after 12 weeks of resistance training correlate with neurochemical markers of brain health in older adults: a randomized controlGeroScience · 2023Trial
- The Effectiveness of a PRoactive Multicomponent Intervention Program on Disability in Independently Living Older People: A Randomized Controlled Trial.The journal of nutrition, health & aging · 2018Trial
- Mechanistic redundancy and hierarchy of aging mechanisms: implications for strategies to extend healthspan and biomarker integration.Frontiers in aging · 2026Review
- Immunotherapeutic targeting of aging-associated isoDGR motif in chronic lung inflammation.Aging cell · 2025Article
- Efficacy of electroacupuncture on insomnia disorder in older adults: study protocol for a multicentre randomised controlled trial.Frontiers in neurology · 2025Article
- Molecular Mechanisms of Exercise and Healthspan.Cells · 2022Review
- Article
- Prevalence and the factors associated with malnutrition risk in elderly Chinese inpatients.Aging medicine (Milton (N.S.W)) · 2021Article
- Metabolic View on Human Healthspan: A Lipidome-Wide Association Study.Metabolites · 2021Article
- Identification of comprehensive geriatric assessment-based risk factors for insomnia in elderly Chinese hospitalized patients.Aging medicine (Milton (N.S.W)) · 2021Article
- Aging and immunotherapies: New horizons for the golden ages.Aging and cancer · 2020Article
- Article
- Article
- Association between renal function and bone mineral density in healthy postmenopausal Chinese women.BMC endocrine disorders · 2019Article
- Traditional Chinese medicine and aging: Integration and collaboration promotes healthy aging.Aging medicine (Milton (N.S.W)) · 2019Article
- Recent Advances in the Systems Biology of Aging.Antioxidants & redox signaling · 2018Review
- How healthy is the healthspan concept?GeroScience · 2018Article
- Heterogeneity of Human Aging and Its Assessment.The journals of gerontology. Series A, Biological sciences and medical sciences · 2017Article
- Barriers to the Preclinical Development of Therapeutics that Target Aging Mechanisms.The journals of gerontology. Series A, Biological sciences and medical sciences · 2016Article
Corrections and comments
- Commented on by
Authors and funding
15 authors.
Funding
Abstract
Although the demographic revolution has produced hundreds of millions people aged 65 and older, a substantial segment of that population is not enjoying the benefits of extended healthspan. Many live with multiple chronic conditions and disabilities that erode the quality of life. The consequences are also costly for society. In the United States, the most costly 5% of Medicare beneficiaries account for approximately 50% of Medicare's expenditures. This perspective summarizes a recent workshop on biomedical approaches to best extend healthspan as way to reduce age-related dysfunction and disability. We further specify the action items necessary to unite health professionals, scientists, and the society to partner around the exciting and palpable opportunities to extend healthspan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.